Lebanon, NH, United States of America
Adimab, LLC
Patents = 48
Trademarks = 8
Forward Citations = 157
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
69 inventors (with patents filed for the assignee):
Adimab is a privately held biotechnology company focused on developing fully human monoclonal antibodies. The company has developed a proprietary yeast-based antibody discovery platform that enables rapid and efficient generation of therapeutic antibodies for a wide range of diseases. Adimab's technology has been utilized to discover and optimize antibody candidates for various partners in the pharmaceutical and biotech industry.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com